ZA202204050B - Test method of particle size and particle size distribution of epristeride drug substance - Google Patents

Test method of particle size and particle size distribution of epristeride drug substance

Info

Publication number
ZA202204050B
ZA202204050B ZA2022/04050A ZA202204050A ZA202204050B ZA 202204050 B ZA202204050 B ZA 202204050B ZA 2022/04050 A ZA2022/04050 A ZA 2022/04050A ZA 202204050 A ZA202204050 A ZA 202204050A ZA 202204050 B ZA202204050 B ZA 202204050B
Authority
ZA
South Africa
Prior art keywords
particle size
epristeride
test method
drug substance
size distribution
Prior art date
Application number
ZA2022/04050A
Inventor
Qiang Lu
Jian Zhao
Ben Niu
Kun Huang
Zhixiang Jia
Linlin Sun
Original Assignee
Jiangsu Lianhuan Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Lianhuan Pharmaceutical Co Ltd filed Critical Jiangsu Lianhuan Pharmaceutical Co Ltd
Publication of ZA202204050B publication Critical patent/ZA202204050B/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/02—Investigating particle size or size distribution
    • G01N15/0205—Investigating particle size or size distribution by optical means

Landscapes

  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Sampling And Sample Adjustment (AREA)
ZA2022/04050A 2021-04-14 2022-04-11 Test method of particle size and particle size distribution of epristeride drug substance ZA202204050B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110403374.8A CN113125317A (en) 2021-04-14 2021-04-14 Method for testing particle size and particle size distribution of epristeride bulk drug

Publications (1)

Publication Number Publication Date
ZA202204050B true ZA202204050B (en) 2022-05-25

Family

ID=76776469

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/04050A ZA202204050B (en) 2021-04-14 2022-04-11 Test method of particle size and particle size distribution of epristeride drug substance

Country Status (2)

Country Link
CN (1) CN113125317A (en)
ZA (1) ZA202204050B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114878441B (en) * 2022-06-15 2023-03-31 山东锐顺药业有限公司 Particle size detection method for agomelatine solid powder

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103411860A (en) * 2013-08-13 2013-11-27 中国检验检疫科学研究院 Powder average particle size determination method
CN107894378B (en) * 2017-06-06 2019-11-29 湖北航天化学技术研究所 A kind of test method of the particle size and its distribution of 5- aminotetrazole
CN109115661A (en) * 2018-09-27 2019-01-01 湖北省宏源药业科技股份有限公司 A method of for measuring azithromycin drug partial size and size distribution
CN109752292A (en) * 2018-12-26 2019-05-14 湖北航天化学技术研究所 A kind of test method of the particle size and its distribution of three aluminum hydrides
CN110044780A (en) * 2019-05-05 2019-07-23 深圳万乐药业有限公司 A kind of test method of Linezolid bulk pharmaceutical chemicals partial size and size distribution

Also Published As

Publication number Publication date
CN113125317A (en) 2021-07-16

Similar Documents

Publication Publication Date Title
IL299896A (en) Methods for encapsulating polynucleotides into reduced sizes of lipid nanoparticles and novel formulation thereof
ZA202204050B (en) Test method of particle size and particle size distribution of epristeride drug substance
EP4201553A4 (en) Preparation method for and use of high-purity powder material and biphasic powder material
GB2547961B (en) Apparatus and method for determination of the fine particle dose of a powder inhalation formulation
HK1232297A1 (en) In vitro method and apparatus for analysing the behaviour of substances in simulated physiological environment
EP3501477A4 (en) Device and method for inspecting preparation of medicines
ZA202306105B (en) Heart-nourishing and nerve-soothing pharmaceutical composition and method for preparation thereof and application thereof
EP4141757A4 (en) Exposure dose measurement simulation apparatus and method
GB2579820B (en) Methods of and apparatus for measuring physiological parameters
HUE060037T2 (en) Apparatus and method for treatment of wrapping material
PL3944867T3 (en) System and method for testing the sterility of radioactive materials
IL306055A (en) System and methods for simulation of medical devices
EP4232139A4 (en) Apparatus and methods for phase-agnostic stimuli
GB202107666D0 (en) Apparatus and method of classification
IL268171A (en) Method and apparatus for examination of cells
EP4076527A4 (en) Therapeutic combinations of drugs and methods of using them
ZA202007640B (en) Method and apparatus for manufacture of dry powders
EP4003306A4 (en) Methods and assemblies for preparing and dispensing lyospheres of pharmaceutical compositions
GB2604011B (en) Security device and method of manufacture thereof
GB202017770D0 (en) Method and apparatus for testing and checking the fit of close-fitting respirators
GB2598549B (en) Mass distribution method and apparatus
GB202103019D0 (en) Biopolyer-inorganic hybrid material and method of preparation
ZA202102092B (en) Pharmaceutical composition comprising rivaroxaban and method of preparation thereof
ZA202005822B (en) Solid dosage form comprising sitagliptin and method of preparation thereof
GB202116249D0 (en) Security device and method of manufacture thereof